TP53 and ovarian carcinoma: In addition to p53, Hakem et al. showed Pirh2 binds and mediates the ubiquitination and proteasome degradation of c-Myc, an oncoprotein frequently overexpressed in various human cancers, including lung, breast, and ovarian cancer [110].